Delivery Order SPE2DB24D9131-SPE2DB24FXRN0
Award Date
7/8/24
Potential Completion Date
7/9/24
Potential Value
$19K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,526.83 firm fixed-price contract is for the supply of Trikafta, a prescription medication used to treat cystic fibrosis. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award...
This is a $18,488.12 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Trikafta, a medication used to treat cystic fibrosis, with an ultimate completion date of April 8, 2025. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit woman-owned small business based in Park Ridge, Illinois. The $18,526.83 contract is for the delivery of Trikafta, a cystic fibrosis medication, with a performance period through April 5, 2024. The contract is awarded under DMS Pharmaceutical Group's indefinite delivery contract SPE2DB with DLA, valued up to $4,999,999 through 2025. This single-award...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $36,637.50 contract is for the delivery of the specialized pharmaceutical product Trikafta, a medication used to treat cystic fibrosis. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract worth $18,526.83 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of the prescription drug Trikafta, which is used to treat cystic fibrosis. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with DLA under the SPE2DB...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,318.75 firm fixed-price contract is for the delivery of Trikafta, a medication used to treat cystic fibrosis. The award is issued under a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA, which allows the agency to issue delivery orders for a...
The U.S. Defense Logistics Agency (DLA) awarded a $18,526.83 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This order for the drug Trikafta is being fulfilled under a larger single-award indefinite delivery contract (IDC), valued up to $499,999,999, awarded to DMS by the DLA. The IDC, which runs through December 31, 2025, allows the DLA to issue delivery orders for a comprehensive range of...
The U.S. government's Defense Logistics Agency (DLA) awarded a delivery order contract valued at $18,526.83 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which has a fixed-price pricing type and a completion date of May 16, 2024, is for the delivery of various pharmaceutical products, including Trikafta, a treatment for cystic fibrosis. This contract is part of a larger indefinite delivery contract (IDC)...
This federal contract was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The firm fixed-price delivery order, valued at $55,580.49, is for the supply of Trikafta, a specialty pharmaceutical product used to treat cystic fibrosis. The contract is part of a larger indefinite delivery contract (IDC) with a ceiling value of up to $499,999,999 that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $37,053.68, is for the delivery of Trikafta 100-50-75 mg/150 mg oral pharmaceutical medication. The contract is a firm fixed-price delivery order placed under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group that has a ceiling value of up to...